FDA PMA FDA Class 3 Approved 🇺🇸 United States

Transcatheter Septal Occluder

PMA: P120021 · Supplement: S020 · Decision Sep 27, 2021
Classifications
1
FEI Numbers
11
Registration Numbers
11

Basic Information

Device Name
Transcatheter Septal Occluder
Trade Name
Amplatzer™ Talisman™ PFO Occluder
PMA Number
P120021
Supplement Number
S020
Device Class
FDA Class 3
Product Code
MLV
Generic Name
Transcatheter septal occluder
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
September 27, 2021
Date Received
April 1, 2021
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for the Amplatzer Talisman PFO Occluder (Talisman PFO); a line extension of the current Amplatzer PFO Occluder (PFO) product family.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MLV Transcatheter Septal Occluder